[The role of endocrine therapy in ovarian cancer].
Emons
G
G
Universitäts-Frauenklinik Marburg.
Ortmann
O
O
Schulz
K D
KD
D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D005260:Female; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000401:mortality / Q000628:therapy*; D010051:Ovarian Neoplasms / Q000401:mortality / Q000628:therapy*; D045167:Progesterone Congeners / Q000009:adverse effects / Q000627:therapeutic use; D015996:Survival Rate; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use; D045165:Testosterone Congeners / Q000009:adverse effects / Q000627:therapeutic use
D006728:Hormones; D045167:Progesterone Congeners; D045165:Testosterone Congeners; D013629:Tamoxifen
Rolle der endokrinen Therapie beim Ovarialkarzinom.